Korea faces regulatory hurdles hindering medical cannabis commercialization despite growth potential

MEDIA


Title	Korea faces regulatory hurdles hindering medical cannabis commercialization despite growth potential2025-04-10 11:18
Writer	neocannbio
Attachment	202504100_NewYork-Presbyterian Hospital.jpg (53.9KB)
Original article : [ChosunBiz] Korea faces regulatory hurdles hindering medical cannabis commercialization despite growth potential

Prev	South Korea's strict insurance barriers hinder access to medical cannabis Epidiolex	neocannbio	2025-04-16
-	Korea faces regulatory hurdles hindering medical cannabis commercialization despite growth potential	neocannbio	2025-04-10
Next	Poor public perception remains biggest hurdle for CBD cosmetics in South Korea	neocannbio	2024-06-10